Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Hays

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 26, 2024
Impact of an enterprise controlled substance management system on labor and inventory costsMichael Mohundro, Thomas Greene, Cindy Moore, et al.
Pharmacy (Basel, Switzerland)|December 27, 2024
Insights from a National Survey on Controlled Substance Diversion Practices in U.S. Hospital Pharmacies: Opportunities for Enhanced Surveillance and ComplianceSamantha S Bastow, Eric P Borrelli, Julia D Lucaci, et al.
Bioanalysis|December 19, 2024
Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serumWilliam T Williams, Kathryn Lindley, Hong Liao, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 8, 2022
ASHP Guidelines on Preventing Diversion of Controlled SubstancesJohn Clark, Toni Fera, Christopher Fortier, et al.
The AAPS Journal|May 5, 2022
Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays?Amanda Hays, Lakshmi Amaravadi, Carmen Fernandez-Metzler, et al.
Pharmaceutical Research|October 25, 2023
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity AssaysElizabeth Butala-Flores, Thien Nguyen, Nithya Selvan, et al.
Bioanalysis|March 10, 2026
Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug developmentCarmen Fernández-Metzler, Karen J Quadrini, Lakshmi Amaravadi, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelinesSara A Monaghan, Steven Eck, Silvia Bunting, et al.
The AAPS Journal|March 12, 2025
Best Practices and Recommendations for Non-Liquid Matrices BioanalysisFaye Vazvaei-Smith, Wenkui Li, Omar S Barnaby, et al.
The AAPS Journal|October 1, 2025
Why is Biomarker Assay Validation Different from that of Pharmacokinetic Assays?Yan G Ni, Lauren F Stevenson, Lakshmi Amaravadi, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 26, 2024
Impact of an enterprise controlled substance management system on labor and inventory costsMichael Mohundro, Thomas Greene, Cindy Moore, et al.
Pharmacy (Basel, Switzerland)|December 27, 2024
Insights from a National Survey on Controlled Substance Diversion Practices in U.S. Hospital Pharmacies: Opportunities for Enhanced Surveillance and ComplianceSamantha S Bastow, Eric P Borrelli, Julia D Lucaci, et al.
Bioanalysis|December 19, 2024
Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serumWilliam T Williams, Kathryn Lindley, Hong Liao, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 8, 2022
ASHP Guidelines on Preventing Diversion of Controlled SubstancesJohn Clark, Toni Fera, Christopher Fortier, et al.
The AAPS Journal|May 5, 2022
Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays?Amanda Hays, Lakshmi Amaravadi, Carmen Fernandez-Metzler, et al.
Pharmaceutical Research|October 25, 2023
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity AssaysElizabeth Butala-Flores, Thien Nguyen, Nithya Selvan, et al.
Bioanalysis|March 10, 2026
Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug developmentCarmen Fernández-Metzler, Karen J Quadrini, Lakshmi Amaravadi, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelinesSara A Monaghan, Steven Eck, Silvia Bunting, et al.
The AAPS Journal|March 12, 2025
Best Practices and Recommendations for Non-Liquid Matrices BioanalysisFaye Vazvaei-Smith, Wenkui Li, Omar S Barnaby, et al.
The AAPS Journal|October 1, 2025
Why is Biomarker Assay Validation Different from that of Pharmacokinetic Assays?Yan G Ni, Lauren F Stevenson, Lakshmi Amaravadi, et al.
Pageof 4